1. Home
  2. GNLX
  3. GNLX News

Latest Genelux Corporation (GNLX) News on August 24, 2025

Genelux doses first subject in Phase II trial of NSCLC treatment

Clinical Trials Arena

10 months ago

Genelux doses first subject in Phase II trial of NSCLC treatment

MT Newswires

a year ago

Top Midday Decliners

MT Newswires

a year ago

Top Premarket Gainers

Share on Social Networks: